These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 26974159)

  • 1. PI3-kinase mutation linked to insulin and growth factor resistance in vivo.
    Winnay JN; Solheim MH; Dirice E; Sakaguchi M; Noh HL; Kang HJ; Takahashi H; Chudasama KK; Kim JK; Molven A; Kahn CR; Njølstad PR
    J Clin Invest; 2016 Apr; 126(4):1401-12. PubMed ID: 26974159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice Carrying a Dominant-Negative Human PI3K Mutation Are Protected From Obesity and Hepatic Steatosis but Not Diabetes.
    Solheim MH; Winnay JN; Batista TM; Molven A; Njølstad PR; Kahn CR
    Diabetes; 2018 Jul; 67(7):1297-1309. PubMed ID: 29724723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncation of Pik3r1 causes severe insulin resistance uncoupled from obesity and dyslipidaemia by increased energy expenditure.
    Kwok A; Zvetkova I; Virtue S; Luijten I; Huang-Doran I; Tomlinson P; Bulger DA; West J; Murfitt S; Griffin J; Alam R; Hart D; Knox R; Voshol P; Vidal-Puig A; Jensen J; O'Rahilly S; Semple RK
    Mol Metab; 2020 Oct; 40():101020. PubMed ID: 32439336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIK3R1 mutations cause syndromic insulin resistance with lipoatrophy.
    Thauvin-Robinet C; Auclair M; Duplomb L; Caron-Debarle M; Avila M; St-Onge J; Le Merrer M; Le Luyer B; Héron D; Mathieu-Dramard M; Bitoun P; Petit JM; Odent S; Amiel J; Picot D; Carmignac V; Thevenon J; Callier P; Laville M; Reznik Y; Fagour C; Nunes ML; Capeau J; Lascols O; Huet F; Faivre L; Vigouroux C; Rivière JB
    Am J Hum Genet; 2013 Jul; 93(1):141-9. PubMed ID: 23810378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance uncoupled from dyslipidemia due to C-terminal PIK3R1 mutations.
    Huang-Doran I; Tomlinson P; Payne F; Gast A; Sleigh A; Bottomley W; Harris J; Daly A; Rocha N; Rudge S; Clark J; Kwok A; Romeo S; McCann E; Müksch B; Dattani M; Zucchini S; Wakelam M; Foukas LC; Savage DB; Murphy R; O'Rahilly S; Barroso I; Semple RK
    JCI Insight; 2016 Oct; 1(17):e88766. PubMed ID: 27766312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice.
    McCurdy CE; Schenk S; Holliday MJ; Philp A; Houck JA; Patsouris D; MacLean PS; Majka SM; Klemm DJ; Friedman JE
    Diabetes; 2012 Oct; 61(10):2495-505. PubMed ID: 22698915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice.
    Zhang Z; Turer E; Li X; Zhan X; Choi M; Tang M; Press A; Smith SR; Divoux A; Moresco EM; Beutler B
    Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6418-E6426. PubMed ID: 27708159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes.
    Mauvais-Jarvis F; Ueki K; Fruman DA; Hirshman MF; Sakamoto K; Goodyear LJ; Iannacone M; Accili D; Cantley LC; Kahn CR
    J Clin Invest; 2002 Jan; 109(1):141-9. PubMed ID: 11781359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
    Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inactivation of class II PI3K-C2α induces leptin resistance, age-dependent insulin resistance and obesity in male mice.
    Alliouachene S; Bilanges B; Chaussade C; Pearce W; Foukas LC; Scudamore CL; Moniz LS; Vanhaesebroeck B
    Diabetologia; 2016 Jul; 59(7):1503-1512. PubMed ID: 27138914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of phosphatidylinositol 3-kinasegamma in the beta-cell: interactions with glucagon-like peptide-1.
    Li LX; MacDonald PE; Ahn DS; Oudit GY; Backx PH; Brubaker PL
    Endocrinology; 2006 Jul; 147(7):3318-25. PubMed ID: 16574789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo studies of a naturally occurring variant of the human p85alpha regulatory subunit of the phosphoinositide 3-kinase: inhibition of protein kinase B and relationships with type 2 diabetes, insulin secretion, glucose disappearance constant, and insulin sensitivity.
    Hansen L; Zethelius B; Berglund L; Reneland R; Hansen T; Berne C; Lithell H; Hemmings BA; Pedersen O
    Diabetes; 2001 Mar; 50(3):690-3. PubMed ID: 11246893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
    Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
    Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage.
    Knauf C; Cani PD; Perrin C; Iglesias MA; Maury JF; Bernard E; Benhamed F; Grémeaux T; Drucker DJ; Kahn CR; Girard J; Tanti JF; Delzenne NM; Postic C; Burcelin R
    J Clin Invest; 2005 Dec; 115(12):3554-63. PubMed ID: 16322793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum leptin protects from adiposity despite the increased glucose uptake in white adipose tissue in mice lacking p85alpha phosphoinositide 3-kinase.
    Terauchi Y; Matsui J; Kamon J; Yamauchi T; Kubota N; Komeda K; Aizawa S; Akanuma Y; Tomita M; Kadowaki T
    Diabetes; 2004 Sep; 53(9):2261-70. PubMed ID: 15331535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
    Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia.
    Luo J; Sobkiw CL; Hirshman MF; Logsdon MN; Li TQ; Goodyear LJ; Cantley LC
    Cell Metab; 2006 May; 3(5):355-66. PubMed ID: 16679293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased insulin sensitivity and hypoglycaemia in mice lacking the p85 alpha subunit of phosphoinositide 3-kinase.
    Terauchi Y; Tsuji Y; Satoh S; Minoura H; Murakami K; Okuno A; Inukai K; Asano T; Kaburagi Y; Ueki K; Nakajima H; Hanafusa T; Matsuzawa Y; Sekihara H; Yin Y; Barrett JC; Oda H; Ishikawa T; Akanuma Y; Komuro I; Suzuki M; Yamamura K; Kodama T; Suzuki H; Yamamura K; Kodama T; Suzuki H; Koyasu S; Aizawa S; Tobe K; Fukui Y; Yazaki Y; Kadowaki T
    Nat Genet; 1999 Feb; 21(2):230-5. PubMed ID: 9988280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent regulation of hepatic glucose and lipid metabolism by phosphoinositide 3-kinase via Akt and PKClambda/zeta.
    Taniguchi CM; Kondo T; Sajan M; Luo J; Bronson R; Asano T; Farese R; Cantley LC; Kahn CR
    Cell Metab; 2006 May; 3(5):343-53. PubMed ID: 16679292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.